Capstan Therapeutics
capstantx.comLocations
Liberty Station, San Diego, CA, USA
industry
Biotechnology · Health Care · Medical · Therapeutics
Size
51 - 200 employees
Stage
Other
founded in
2021
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases using its proprietary CellSeeker tLNP platform. Its technology deploys targeted lipid nanoparticles conjugated with protein binders—such as antibodies—to reprogram specific cell types within the body, including CAR-T cells, without ex vivo manipulation. The lead candidate, CPTX2309, delivers an anti-CD19 CAR payload to CD8⁺ T cells and aims to reset B cell–driven autoimmune disease, currently in Phase 1 trials.
Something looks off?Open jobs at Capstan Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.